臨床試験を検索:抗生物質(優先的に経口ドキシサイクリン 100 mg 入札)
合計402件
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany完了
-
N-Gene Research Laboratories, Inc.Thermo Fisher Scientific, Inc; Integrium; Msource Medical Development GmbH; Kinexum LLC; Haupt Pharma... と他の協力者終了しました
-
Bristol-Myers Squibb完了
-
Enteris BioPharma Inc.Syneos Health; Parexel募集
-
University Medical Centre LjubljanaUniversity of Ljubljana School of Medicine, Slovenia完了
-
University of JenaNovartis Pharmaceuticals; Ludwig-Maximilians - University of Munich積極的、募集していない
-
University Medical Centre LjubljanaMedical University of Vienna; Harvard University; University of Ljubljana School of Medicine,...わからない
-
Vifor (International) Inc.Labcorp Drug Development Inc引きこもった
-
ViiV HealthcareGlaxoSmithKline終了しました感染症、ヒト免疫不全ウイルスアメリカ, カナダ, イタリア, ベルギー, ルーマニア
-
Haiphong University of Medicine and Pharmacy完了
-
Ron PostumaCanadian Institutes of Health Research (CIHR); University of Toronto完了
-
Galderma R&D完了
-
gicare Pharma Inc.Algorithme Pharma Inc完了
-
Memorial Sloan Kettering Cancer CenterSanofi; Weill Medical College of Cornell University; Thomas Jefferson University完了
-
Medicines for Malaria VentureWashington University School of Medicine; Sanaria Inc.; Institute of Tropical Medicine, Belgium; SGS Life Sciences, a division of SGS Belgium NV と他の協力者完了
-
Institute of Hematology & Blood Diseases Hospitalまだ募集していませんAAのHSCT患者におけるaGVHDに対するルキソリチニブの予防的価値
-
Emerald Health Pharmaceuticals一時停止
-
Rabin Medical CenterTel Aviv University; The Leona M. and Harry B. Helmsley Charitable Trust募集
-
Morten LindbaekNorwegian Institute of Public Health; Sorlandet Hospital HF; Norwegian University of Life Sciences完了
-
University Hospital, Ghent完了
-
AstraZeneca完了
-
Cassava Sciences, Inc.National Institute on Aging (NIA)完了
-
Kirby Institute募集